Cargando…
Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case–control study
BACKGROUND: The effects of oral antihyperglycaemic drugs (OADs) for type 2 diabetes mellitus (T2DM) on the outcomes of co-existing chronic obstructive pulmonary disease (COPD) patients are not well studied. We examined the association of combinational OADs and the risk of acute exacerbations of COPD...
Autores principales: | Chen, Kuan-Yuan, Wu, Sheng-Ming, Tseng, Chien-Hua, Lee, Kang-Yun, Lin, Yu-Huei, Liu, Hung-Yi, Chien, Li-Nien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086317/ https://www.ncbi.nlm.nih.gov/pubmed/33926423 http://dx.doi.org/10.1186/s12890-021-01505-7 |
Ejemplares similares
-
Thiazolidinediones are associated with a reduced risk of COPD exacerbations
por: Rinne, Seppo T, et al.
Publicado: (2015) -
Cooperative impact of thiazolidinedione and fatty acid synthase on human osteogenesis
por: Chen, Ching-Yun, et al.
Publicado: (2019) -
Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan
por: Tseng, Chin-Hsiao
Publicado: (2023) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015) -
Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)